Tumor cell membrane disruption via viral envelope fusion proteins

Viral envelope fusion proteins are transmembrane glycoproteins that mediate the fusion of viral and host cell membranes. In cancer therapy, these proteins, or peptides derived from them, can be engineered to target and disrupt tumor cell membranes, leading to cell death. This approach leverages the fusogenic properties of viral proteins to overcome energy barriers that prevent spontaneous membrane fusion, resulting in targeted tumor cell lysis and potentially stimulating anti-tumor immunity.

Other names

Viral fusion protein-mediated tumor cell lysisFusogenic glycoprotein-mediated tumor cell disruption

Conformational change leading to insertion of hydrophobic fusion peptide into target membrane, followed by hemifusion and pore formation, resulting in membrane disruption and cell lysis.